HEXA rs28931589: Understanding This Tay-Sachs Carrier Variant

What each genotype means

What is the rs28931589 Variant?

The rs28931589 variant is a single nucleotide change located within the HEXA gene, which is situated on chromosome 15. In scientific literature, this specific mutation is often referred to by its clinical nomenclature, c.1421+1G>C. This notation indicates that the change occurs at the first nucleotide of an intron, a region that is typically spliced out during the process of creating functional proteins. Because this position is critical for the cellular machinery that correctly processes genetic instructions, a change here—specifically from a guanine (G) to a cytosine (C)—can disrupt the splicing process. This disruption often leads to the production of a non-functional or unstable protein, which is why it is classified as a splice donor variant. Understanding the location of this variant helps researchers and clinicians predict how it might interfere with the normal expression of the gene.

The Role of the HEXA Gene

The HEXA gene provides the essential instructions for the body to produce the alpha subunit of an enzyme called beta-hexosaminidase A. This enzyme is a vital component of the lysosome, the cell's recycling center. Its primary function is to break down a fatty substance known as GM2 ganglioside. When the HEXA gene functions correctly, this process prevents the toxic accumulation of these fatty substances in the nervous system. However, when pathogenic variants like rs28931589 are present, the production of functional beta-hexosaminidase A is significantly reduced or absent. This deficiency leads to the progressive accumulation of GM2 gangliosides, which is the underlying cause of the clinical spectrum of HEXA disorders, including Tay-Sachs disease. Because the body requires this enzyme for healthy neurological function, mutations that severely impact its activity are considered clinically significant.

Research and Clinical Significance

Research has established that rs28931589 is a pathogenic variant linked to Tay-Sachs disease, an autosomal recessive condition. This means that an individual typically needs to inherit two copies of a pathogenic variant—one from each parent—to manifest the disease. Carriers, who possess only one copy of the variant, generally do not show symptoms of the disease because their remaining functional copy of the HEXA gene produces enough enzyme to maintain normal cellular function. The evidence for this variant's pathogenicity is well-documented in clinical databases like ClinVar, where it is identified as a cause of hexosaminidase A deficiency. While it is a known pathogenic marker, it is just one of many possible mutations in the HEXA gene. Clinical testing for this variant is often performed as part of a targeted panel for individuals with a family history of the condition or those from populations with a higher known carrier frequency.

Population Frequency and Distribution

The frequency of the rs28931589 variant varies significantly across different ancestral groups. Globally, the allele frequency is quite low, estimated at approximately 0.0001 in large-scale databases like gnomAD. However, genetic epidemiology has shown that this variant is notably enriched in specific populations, particularly among French Canadians. This enrichment is often attributed to the founder effect, where a small, isolated population expands, leading to a higher prevalence of certain genetic traits that were present in the original group. Other groups, such as the Ashkenazi Jewish population, also have well-documented carrier frequencies for various HEXA mutations, though the specific variants involved can differ. Because of this population-specific distribution, genetic screening programs often tailor their testing panels to include the most common pathogenic variants relevant to the individual's ancestry.

Interpreting Your Genetic Information

If you have received information regarding your status for the rs28931589 variant, it is important to understand what this means in a broader context. Being identified as a carrier for an autosomal recessive condition is common, as most people carry several recessive variants for various conditions. This information is primarily used for reproductive planning and family health awareness. It is not a diagnosis of a disease, nor does it imply that you will develop symptoms. If you are concerned about your carrier status or have a family history of Tay-Sachs disease, the most appropriate step is to consult with a certified genetic counselor or a medical professional. They can help you interpret your results, discuss the implications for your family, and explain the options for further testing or screening. Never make medical decisions based solely on genetic reports without professional clinical guidance.

Frequently asked questions

Sources & further reading

Related variants in HEXA